[talk] Internet Histories at UCLA

I'm giving a talk for the Information Studies Department at UCLA this Thursday.

Celebrate the Future that Never Was!

If you're in Hollywood this April 28, drop by the Arclight Theater to celebrate the future that never was with Obscura Day, the BBC, and Matt Novak of Paleofuture fame:

Join Atlas Obscura and BBC Future’s Matt Novak for retro cocktails at his first-ever gallery installation set in the future seen through the eyes of the past. A romp through retrofuturism will transport us to a world ruled by airships, pneumatic tubes, and space elevators.

Sign up here.  I'll even be talking a bit.

Thinner, Happier, and Less Reactive

I'm a fan of the Alcohol and Drugs History Society's Points Blog, so I am happy to be guest blogging four posts for them over the next month.  My first post is on Qnexa, a recently approved weight loss pill, which is really just a repackaged mood stabilizer.  Read on.

[talk] The Patient-Profit Relationship In U.S. Pharmaceutical Markets

This talk is in a few hours, but I thought I would post it anyways, thereby alerting you to the great colloquia and conferences put on by the UCLA Department of History.

(Bunche 5288, from February 13, 2012 04:00 PM)

[course] Introduction to Internet History: 1960 to the Present

I am developing a course entitled "Introduction to Internet History: 1960 to the Present," which I will teach this summer at the UCLA Department of History.

[talk] Mental Health and Economic History: Changes in Antipsychotic Drug Markets in the US, c. 1960-2000

From the good people at the Research Forum in Medical History and the Medical Humanities:

"12:30 pm, Friday, January 20, 2011
Rare Book Room, History and Special Collections
9th level, Louise M. Darling Biomedical Library 

Brad Fidler, PhD, 2011, UCLA Department of History 

Mental Health and Economic History: Changes in Antipsychotic Drug Markets in the US, c. 1960-2000 

A new generation of antipsychotic medications introduced in the 1980s and 1990s is distinguished less by health outcomes than the economics of American (and global) pharmaceuticals in the late twentieth century.  In this talk, Dr. Fidler looks to these new drugs as a way to understand the significance and historical context of the changing structure and function of psychiatric drug marketing in the US."

You need to RSVP to other people at this email address.

Defend the patriarchy!

You Should Come To This Party